BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Athauda D, Evans J, Wernick A, Virdi G, Choi ML, Lawton M, Vijiaratnam N, Girges C, Ben-Shlomo Y, Ismail K, Morris H, Grosset D, Foltynie T, Gandhi S. The Impact of Type 2 Diabetes in Parkinson's Disease. Mov Disord 2022;37:1612-23. [PMID: 35699244 DOI: 10.1002/mds.29122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhong Q, Wang S. Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis. Front Aging Neurosci 2023;15. [DOI: 10.3389/fnagi.2023.1109914] [Reference Citation Analysis]
2 Cullinane PW, de Pablo Fernandez E, König A, Outeiro TF, Jaunmuktane Z, Warner TT. Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Mov Disord 2023;38:162-77. [PMID: 36567671 DOI: 10.1002/mds.29298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Klein C, Bloem BR. Research in movement disorders in 2022: a new era of biomarker and treatment development. Lancet Neurol 2023;22:17-9. [PMID: 36517158 DOI: 10.1016/S1474-4422(22)00494-X] [Reference Citation Analysis]
4 Chen J, Zhao D, Wang Q, Chen J, Bai C, Li Y, Guo X, Chen B, Zhang L, Yuan J. Predictors of cognitive impairment in newly diagnosed Parkinson's disease with normal cognition at baseline: A 5-year cohort study. Front Aging Neurosci 2023;15:1142558. [PMID: 36926634 DOI: 10.3389/fnagi.2023.1142558] [Reference Citation Analysis]
5 Faizan M, Sarkar A, Singh MP. Type 2 diabetes mellitus augments Parkinson's disease risk or the other way around: Facts, challenges and future possibilities. Ageing Res Rev 2022;81:101727. [PMID: 36038113 DOI: 10.1016/j.arr.2022.101727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Eschle D. Lebensstil und Parkinson-Risiko. J Klin Endokrinol Stoffw 2022. [DOI: 10.1007/s41969-022-00174-z] [Reference Citation Analysis]
7 Li N, Zhou T, Fei E. Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders. IJMS 2022;23:8281. [DOI: 10.3390/ijms23158281] [Reference Citation Analysis]
8 Vijiaratnam N, Lawton M, Real R, Heslegrave AJ, Guo T, Athauda D, Gandhi S, Girges C, Ben-Shlomo Y, Zetterberg H, Grosset DG, Morris HR, Foltynie T; PRoBaND Clinical Consortium. Diabetes and Neuroaxonal Damage in Parkinson's Disease. Mov Disord 2022;37:1568-9. [PMID: 35856732 DOI: 10.1002/mds.29067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]